Randomised trial comparing combinations of cyclophosphamide and cisplatin without or with doxorubicin or 4′-epi-doxorubicin in the treatment of advanced ovarian cancer-Reference-Cited by-同舟云学术

Randomised trial comparing combinations of cyclophosphamide and cisplatin without or with doxorubicin or 4′-epi-doxorubicin in the treatment of advanced ovarian cancer

Published:1988-10 Issue:2 Volume:27 Page:199-204
ISSN:0020-7292
Container-title:International Journal of Gynecology & Obstetrics
language:en
Short-container-title:International Journal of Gynecology & Obstetrics

Author:

Hernádi Z.,Juhász B.,Póka R.,Lampé L.G.

Publisher

Wiley

Subject

Obstetrics and Gynecology,General Medicine

Reference14 articles.

1. Epirubicin;Bonadonna,1984

2. Clinical spectrum of anthracycline antibiotic cardiotoxicity;Bristow;Cancer Treat Rep,1978

3. Chemotherapy of ovarian cancer with adriamycin (ADM) and cis-platinum (DDP);Bruckner;Proc Am Assoc Cancer Res ASCO,1976

4. Experimental evaluation of anthracycline analogs;Casazza;Cancer Treat Rep,1979

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protocol Development for Ovarian Cancer Treatment in Kenya: A Brief Report;International Journal of Gynecologic Cancer;2011-01

2. Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials;BMC Cancer;2010-06-29

3. Different anthracycline derivates for reducing cardiotoxicity in cancer patients;Cochrane Database of Systematic Reviews;2010-05-12

4. Different anthracycline derivates for reducing cardiotoxicity in cancer patients;Cochrane Database of Systematic Reviews;2010-03-17

5. Different anthracycline derivates for reducing cardiotoxicity in cancer patients;Cochrane Database of Systematic Reviews;2006-10-18